newsfilter
← Latest News
GlobeNewswire·

Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting